In addition, the role of MUC1 expressing level in affecting drug efficiency need to be validated with different kind of canine mammary tumors, and the molecular mechanism of interactions between MUC1 and PI3K/Akt/mTOR needs to be investigated as well. This evidence concerns the gene AKT1 and breast cancer.